Cochrane Evidence Synthesis and Methods ►

Gene therapy for people with hepatocellular carcinoma

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the benefits and harms of gene therapy in people with hepatocellular carcinoma, irrespective of sex, administered dose, and type of formulation.

This is a protocol.

Health topics:

Cancer > Liver

Gastroenterology & hepatology > Cancer: other gastrointestinal

Published:

15 September 2020

Authors:

Naing C, Leong C-O, Aung HH, Mai C-W, Chan EW, Kew ST

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Naing C, Leong C-O, Aung HH, Mai C-W, Chan EW, Kew ST. Gene therapy for people with hepatocellular carcinoma (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No.: CD013731. DOI: 10.1002/14651858.CD013731.